If a study was able to determine that IL17 target therapy can both control tumor diseases and lead to resolution of SARS-CoV-2 infection, it could be applied as a treatment for SARS-CoV-2 patients with lung cancer [51]. Here, IL17A is linked to lung carcinoma.